The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
LLY · Healthcare · Wide moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | ICUI | IDXX | LLY | RMD |
|---|---|---|---|---|
| Moat Score (0–100) | 30 | 96 (highest) | 94 | 94 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 55 | 90 | 95 | 100 (highest) |
| Pricing power | 48 | 96 | 99 (highest) | 96 |
| Returns on capital | 4 | 100 (highest) | — | 96 |
| Balance-sheet safety | 0 | 98 | 83 | 100 (highest) |
| Capital allocation | 41 | 97 | 100 (highest) | 77 |
| 219% above value if growth stopped today | 376% above value if growth stopped today | 1609% above value if growth stopped today | 182% above value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $4.0B | $44.7B | $1.19T | $34.5B |
| Moat tier | No moat | Wide moat | Wide moat | Wide moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2026 |